The Oncology Institute, Inc.
TOI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$53,005 | -$83,068 | $152 | -$10,927 |
| Dep. & Amort. | $6,287 | $5,873 | $4,411 | $3,341 |
| Deferred Tax | $0 | -$76 | -$263 | -$1,242 |
| Stock-Based Comp. | $0 | $17,810 | $27,683 | $24,535 |
| Change in WC | $18,059 | $2,359 | -$20,541 | -$14,489 |
| Other Non-Cash | $2,121 | $20,787 | -$73,198 | -$33,898 |
| Operating Cash Flow | -$26,538 | -$36,315 | -$61,756 | -$32,680 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,789 | -$4,567 | -$5,529 | -$2,847 |
| Net Acquisitions | $0 | -$4,456 | -$8,577 | -$9,107 |
| Inv. Purchases | $0 | -$9,595 | -$117,508 | $0 |
| Inv. Sales/Matur. | $50,000 | $81,258 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | -$200 |
| Investing Cash Flow | $46,211 | $62,640 | -$131,614 | -$12,154 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$39 | -$101 | $109,942 | -$7,251 |
| Stock Issued | $75 | $0 | $0 | $0 |
| Stock Repurch. | $0 | -$1,019 | -$9,000 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$3,528 | -$5,727 | -$8,736 | $161,261 |
| Financing Cash Flow | -$3,492 | -$6,847 | $92,206 | $154,010 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $16,181 | $19,478 | -$101,164 | $109,176 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $33,488 | $14,010 | $115,174 | $5,998 |
| End Cash | $49,669 | $33,488 | $14,010 | $115,174 |
| Free Cash Flow | -$30,327 | -$40,882 | -$67,285 | -$35,727 |